Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
Clinical trial NCT06408194 · RECRUITING
Trial details
- NCT number
- NCT06408194
- Sponsor
- Stanford University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-13
- Primary completion
- 2026-07-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.